Clinical Trials for Schizoaffective Disorder

Accelerated TMS in Psychosis

NCT ID: NCT05567848

Characterizing Response to Antipsychotics in Schizophrenia

NCT ID: NCT06159322

This clinical trial is focused on improving how we treat people with schizophrenia and schizoaffective disorder. Researchers want to find out if brain scans (using MRI technology) can help identify...

Cognitive Behavioral Therapy for Insomnia (CBT-I) in Schizophrenia(SLEEPINS)

NCT ID: NCT04144231

This clinical trial, called SLEEPINS, is studying how cognitive behavioral therapy for insomnia (CBT-I) can help people with schizophrenia and schizoaffective disorder improve their sleep and overa...

Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia

NCT ID: NCT02639702

This clinical trial is studying whether switching patients with schizophrenia or schizoaffective disorder from taking clozapine twice a day to once a day is safe and effective. Researchers want to ...

SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities

NCT ID: NCT06007105

The SUCCEED Africa trial is focused on developing and testing a new support program for people living with serious mental health conditions, such as schizophrenia and bipolar disorder with psychoti...

Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department

NCT ID: NCT05974527

This clinical trial is looking at a medication called BXCL501, which is a type of film that dissolves under the tongue, to see if it can help reduce agitation in patients who come to the emergency ...

Brain Health and Exercise in Schizophrenia

NCT ID: NCT01392885

This clinical trial, called "Brain Health and Exercise in Schizophrenia," is looking at how aerobic exercise might help improve brain health and reduce symptoms in people with schizophrenia and sch...

Integrated Care in Psychotic Disorders With Severe Mental Illness

NCT ID: NCT01888627

This clinical trial is studying a special care program designed for people with severe mental illnesses, particularly those with psychotic disorders like schizophrenia and bipolar disorder. The goa...

Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates

NCT ID: NCT03495024

This clinical trial is investigating whether a medication called varenicline can help patients with schizophrenia or schizoaffective disorder quit smoking and if it can improve neurological symptom...